Loading...
•
Sep 30, 2024
Health Catalyst Q3 2024 Earnings Report
Reported strong financial results with revenue of $76.4 million and Adjusted EBITDA of $7.3 million, exceeding guidance.
Key Takeaways
Health Catalyst reported strong financial results for Q3 2024, with total revenue of $76.4 million and Adjusted EBITDA of $7.3 million, both exceeding the midpoint of their quarterly guidance. They are raising their Adjusted EBITDA guidance by $1 million for 2024.
Total revenue reached $76.4 million.
Adjusted EBITDA was $7.3 million.
Adjusted EBITDA guidance raised by $1 million for 2024.
Company is focused on driving profitable growth and scaling.
Revenue by Segment
Forward Guidance
Health Catalyst provides forward-looking guidance on total revenue and Adjusted EBITDA. For the fourth quarter of 2024, they expect total revenue between $78.0 million and $84.0 million, and Adjusted EBITDA between $6.8 million and $8.8 million. For the full year of 2024, they expect total revenue between $305.0 million and $311.0 million, and Adjusted EBITDA between $25.0 million and $27.0 million.
Positive Outlook
- Total revenue between $78.0 million and $84.0 million for Q4 2024.
- Adjusted EBITDA between $6.8 million and $8.8 million for Q4 2024.
- Total revenue between $305.0 million and $311.0 million for the full year 2024.
- Adjusted EBITDA between $25.0 million and $27.0 million for the full year 2024.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...